Search

A short overview of the evolution of botulinum toxin type A formulations

Botulinum toxin type A (BoNT-A) is a potent neurotoxin produced by the bacterium Clostridium botulinum [1]. BoNT-A has been used for various therapeutic and aesthetic purposes, including the treatment of muscle disorders, chronic pain and facial wrinkles [2-4]. Over the...

Stratifying preoperative risk in revision augmentation: the six Cs

Breast augmentation is the most frequently performed cosmetic surgical procedure in the UK [1], and with an increasing number of providers, plastic surgeons are managing revisions without information pertaining to the original procedure. Anticipating the features of successive generations of...

We need to talk about amputation – a difficult conversation in the developing world

What do you do when a patient refuses amputation? The author shares various cases and outlines her team’s approach to this scenario in Gaza. What to do when a patient refuses amputation for a severely damaged lower limb that will...